Charcot-Marie-Tooth Disease Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Study to Assess the Efficacy and Safety of PXT3003 in Charcot-Marie-Tooth Type 1A
Condition: Charcot-Marie-Tooth Type 1A Interventions: Drug: PXT3003; Drug: PXT3003 placebo Sponsor: Tasly Pharmaceutical Group Co., Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2021 Category: Research Source Type: clinical trials
